Overview
Financials
Revenue history (in m)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2013-11-01. Active
61 1050 0086 1000 0024 4188 0016
26 1050 0086 1000 0090 3026 0229
90 1050 0086 1000 0090 8151 1355
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $2.3M$2,259,669 |
Buildings and premises | $24.9M$24,884,731 |
Investment property | $6.4M$6,353,842 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 31, 2020 | Regional investment aid | $45,443$45,443 | Prezydent Miasta Katowice | |
| Jan 31, 2019 | Regional investment aid | $173.1K$173,124 | Prezydent Miasta Katowice | |
| Jan 31, 2018 | Regional investment aid | $107.2K$107,178 | Prezydent Miasta Katowice |
Tenders
No recorded participation in tenders.
Trademarks
Farmacore holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2013.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| SILESIANPHARMA | Z.539816 | 3, 5, 10, 16, 35, 38, 39, 41, 42, 44 | Protected | Feb 11, 2032 | |
| FP FARMAPROFIT | Z.417830 | 9, 35, 36, 40, 41, 42, 44 | Protected | Aug 14, 2033 |
| Mark | Protected until | |
|---|---|---|
| SILESIANPHARMA | Feb 11, 2032 | |
| FP FARMAPROFIT | Aug 14, 2033 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of appointing a one-person management board, the sole member of the management board is authorized to make declarations of will and represent the company, and in the case of appointing a multi-member management board, two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 474 | $2,289.03 | 0.0001% | |
Farmacol S.A. | 41,881 | – | – |
Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-szczecin S.A. | 8,484 | $2,291.73 | 0.0001% |
| 452 | $2,214,264,573.74 | 99.9998% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Farmacol-Logistykasp. z o.o. | 130,097,676.93 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| 12 - Archicom Projekt 127S.K.A. | $75,495,040.83 | echo.com.pl | ||
| Dolnośląskie Centrum Hurtu Rolno-SpożywczegoS.A. | $6,850,108.05 | dchrs.com.pl | ||
| Saller Polbau Poland Projekt Deltasp. z o.o. + limited partnership | $5,062,768.55 | saller.pl | ||
| Belayo LtdS.K.A. | $4,930,728.79 | belayo.pl | ||
| Pure Rentalsp. z o.o. | $1,732,264.35 | purerental.pl | ||
| Citylink Wrocław IIsp. z o.o. | $1,455,411.33 | city-link.pl | ||
| Kontorsp. z o.o. + limited partnership | $1,409,907.84 | kontor.pl | ||
| Moda WrocławS.A. | $1,084,804.72 | modawroclaw.pl | ||
| Surfland Kuciewiczsp. k. | $976,656.03 | surfland.pl | ||
| Wrocapartmentssp. z o.o. | $945,158.45 | wrocapartments.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-04-28 | Share capital change (7,803,700.00 PLN → 7,825,620.00 PLN) | |
| 2021-12-30 | Share capital change (6,147,900.00 PLN → 7,803,700.00 PLN) | |
| 2021-12-23 | Share capital change (4,800,100.00 PLN → 6,147,900.00 PLN) | |
| 2021-12-16 | Share capital change (4,800,000.00 PLN → 4,800,100.00 PLN) | |
| 2021-10-04 | Share capital change (1,400,000.00 PLN → 4,800,000.00 PLN) |
FAQ
Last updated: 2026-10-07

